Healthcare venture investing reached its highest level in five quarters, with signs of a resurgence in early stage investing.
Healthcare companies received $1.9 billion in investment during the second quarter, up 21 percent from the prior quarter and up 16 percent from the like quarter last year, according to a report from New York research firm CB Insights. There were 147 venture-backed healthcare deals in the quarter.
The quarter’s largest healthcare deals included: California-based defibrillator company Cameron Health ($107 million), Massachusetts-based cancer drug developer Tesaro ($101 million) and Massachusetts-based osteoporosis drug developer Radius ($91 million).
To read the full, original article click on this link: Healthcare venture capital investment hits five-quarter high
Author:Brandon Glenn
